<title>VIVUS, Inc. (VVUS) News & Commentary

DJIA

15,387.58

52.30

0.34%

NASDAQ

3,502.12

5.69

0.16%

S&P 500

1,669.16

2.87

0.17%

5/1/2013 by Seeking Alpha

4/30/2013 by Zacks

A primer on drug names used by biotech companies.

4/30/2013 by DailyFinance

VIVUS Names Robert Wilson to Board; Says Entered Into Commercial Rebate Pact with Medco April, Patients to Pay Estimated $50-60 Copay

4/30/2013 by Benzinga

4/29/2013 by Zacks

4/29/2013 by Zacks

Apple's impact on health care has been nothing short of revolutionary. Here's why.

4/27/2013 by DailyFinance

4/24/2013 by Seeking Alpha

4/23/2013 by Zacks

4/22/2013 by Zacks